Evaluation of Desensitization Protocols in Reduction of Dentin Hypersensitivity
NCT ID: NCT03076944
Last Updated: 2017-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2017-03-20
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment
NCT02931734
Control of Pain Due to Dentin Hypersensitivity in Individuals With Molar-incisor Hypomineralization
NCT04407702
Effect of Seashell Nanoparticles and Gluma Desensitizer on Sensitivity of Teeth
NCT06622018
Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions
NCT04642001
Treatment of Dentin Hypersensitivity Using Different Desensitizing Agents
NCT04340869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neural agent
UltraEZ. Prophylaxis of the teeth; an application every 48 hours; 4 sessions
UltraEZ
Prophylaxis, apply uniformly on the teeth, wait 15 minutes, remove the gel from the teeth with cotton and abundant water.
Obliterator agent
Enamelast. Prophylaxis of the teeth; an application every 48 hours; 4 sessions
Enamelast
Prophylaxis; dry the teeth; apply uniformly on the teeth with a thin layer.
Associative approach
UltraEZ and Enamelast. Prophylaxis of the teeth; an application every 48 hours; 4 sessions. In each session, fistly the UltraEZ (neural agent) will be applied and after the Enamelast (obliterator agent.)
UltraEZ
Prophylaxis, apply uniformly on the teeth, wait 15 minutes, remove the gel from the teeth with cotton and abundant water.
Enamelast
Prophylaxis; dry the teeth; apply uniformly on the teeth with a thin layer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UltraEZ
Prophylaxis, apply uniformly on the teeth, wait 15 minutes, remove the gel from the teeth with cotton and abundant water.
Enamelast
Prophylaxis; dry the teeth; apply uniformly on the teeth with a thin layer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genres, interested in the treatment of Dentin Hypersensitivity
* Patients with all teeth in their mouth
* Patients who have at least three teeth with Dentin hypersensitivity in different quadrants
* Good oral hygiene
Exclusion Criteria
* Presence of periodontal disease and or parafunctional habits
* Cracks or enamel fractures
* Extensive or unsatisfactory restorations
* Recent restorations involving the labial surface
* Pulpitis
* Dentures
* Orthodontics
* Smokers
* Pregnant women
* Gastroesophageal disease presence
* Uncontrolled systemic disease
* Severe bruxism
* Constant use of analgesic
* Allergic response to dental products
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
OTHER_GOV
Fundação de Amparo à Pesquisa do estado de Minas Gerais
OTHER
Federal University of Uberlandia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PAULO VINICIUS SOARES
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paulo V Soares, DDS, MS, PHD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Uberlandia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Uberlândia
Uberlândia, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Orchardson R, Gangarosa LP Sr, Holland GR, Pashley DH, Trowbridge HO, Ashley FP, Kleinberg I, Zappa U. Dentine hypersensitivity-into the 21st century. Arch Oral Biol. 1994;39 Suppl:113S-119S. doi: 10.1016/0003-9969(94)90197-x. No abstract available.
Davari A, Ataei E, Assarzadeh H. Dentin hypersensitivity: etiology, diagnosis and treatment; a literature review. J Dent (Shiraz). 2013 Sep;14(3):136-45.
Canadian Advisory Board on Dentin Hypersensitivity. Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc. 2003 Apr;69(4):221-6.
Brannstrom M. Sensitivity of dentine. Oral Surg Oral Med Oral Pathol. 1966 Apr;21(4):517-26. doi: 10.1016/0030-4220(66)90411-7. No abstract available.
Grippo JO, Simring M, Coleman TA. Abfraction, abrasion, biocorrosion, and the enigma of noncarious cervical lesions: a 20-year perspective. J Esthet Restor Dent. 2012 Feb;24(1):10-23. doi: 10.1111/j.1708-8240.2011.00487.x. Epub 2011 Nov 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE:60751416.1.0000.5152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.